Free Trial

Plexus Corp. (NASDAQ:PLXS) Receives $152.00 Average PT from Brokerages

Plexus logo with Computer and Technology background

Key Points

  • Plexus Corp. (NASDAQ: PLXS) has received a consensus rating of "Moderate Buy" from five ratings firms, with an average 12-month target price of $152.00.
  • Insider transactions include COO Oliver K. Mihm selling 2,102 shares, and CAO Angelo Michael Ninivaggi, Jr. selling 1,576 shares, representing decreases in their stock positions.
  • The company reported a Q2 earnings of $1.90 EPS, surpassing analysts' expectations, and set guidance for Q4 2025 EPS between $1.820 and $1.970.
  • Five stocks to consider instead of Plexus.

Shares of Plexus Corp. (NASDAQ:PLXS - Get Free Report) have received an average recommendation of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $152.00.

A number of equities research analysts have issued reports on PLXS shares. Needham & Company LLC decreased their price target on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a report on Thursday, July 24th. Stifel Nicolaus set a $140.00 target price on Plexus in a research note on Thursday, July 24th. Wall Street Zen lowered Plexus from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 16th. Benchmark reiterated a "buy" rating and set a $160.00 price target on shares of Plexus in a report on Wednesday, June 4th. Finally, Sidoti raised Plexus from a "neutral" rating to a "buy" rating and increased their price objective for the company from $135.00 to $150.00 in a research report on Friday, July 25th.

Check Out Our Latest Report on Plexus

Plexus Stock Performance

PLXS stock traded up $3.94 during midday trading on Friday, hitting $142.20. 49,422 shares of the company traded hands, compared to its average volume of 175,239. Plexus has a twelve month low of $103.43 and a twelve month high of $172.89. The stock has a market capitalization of $3.84 billion, a price-to-earnings ratio of 24.12 and a beta of 0.82. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The business has a 50 day simple moving average of $133.38 and a 200-day simple moving average of $130.05.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the previous year, the company earned $1.45 earnings per share. Plexus's revenue for the quarter was up 6.0% on a year-over-year basis. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. As a group, equities research analysts predict that Plexus will post 5.9 earnings per share for the current year.

Insider Transactions at Plexus

In related news, insider Victor (Pang Hau) Tan sold 3,000 shares of the stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $139.00, for a total value of $417,000.00. Following the completion of the sale, the insider owned 8,723 shares in the company, valued at approximately $1,212,497. This trade represents a 25.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of Plexus stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $137.78, for a total value of $217,141.28. Following the sale, the chief accounting officer directly owned 24,495 shares in the company, valued at approximately $3,374,921.10. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 14,356 shares of company stock worth $1,926,890. 1.76% of the stock is currently owned by insiders.

Institutional Trading of Plexus

A number of hedge funds have recently modified their holdings of the company. State Street Corp increased its position in shares of Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company's stock valued at $143,361,000 after purchasing an additional 24,115 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in Plexus by 0.6% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company's stock worth $125,005,000 after buying an additional 6,257 shares in the last quarter. American Century Companies Inc. increased its holdings in Plexus by 12.9% in the 2nd quarter. American Century Companies Inc. now owns 765,773 shares of the technology company's stock valued at $103,617,000 after buying an additional 87,551 shares during the period. Nuveen Asset Management LLC raised its stake in shares of Plexus by 6.6% in the 4th quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock valued at $55,012,000 after buying an additional 21,911 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Plexus by 120.4% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock worth $44,655,000 after acquiring an additional 190,360 shares during the period. Institutional investors own 94.45% of the company's stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.